Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
3,342
+454
+16% +$174K 0.01% 1193
2026
Q1
$929K Buy
2,888
+180
+7% +$48.7K ﹤0.01% 1346
2025
Q4
$589K Buy
2,708
+288
+12% +$60.4K ﹤0.01% 1523
2025
Q3
$515K Buy
2,420
+220
+10% +$40.3K ﹤0.01% 1423
2025
Q2
$375K Buy
2,200
+55
+3% +$7.92K ﹤0.01% 1498
2025
Q1
$248K Buy
2,145
+247
+13% +$33.3K ﹤0.01% 1508
2024
Q4
$260K Sell
1,898
-2
-0.1% -$268 ﹤0.01% 1412
2024
Q3
$234K Buy
+1,900
New +$207K ﹤0.01% 1229
2023
Q3
Sell
-1,750
Closed -$206K 192
2023
Q2
$206K Buy
+1,750
New +$171K 0.09% 170

Other funds holding MTZ

&Partners's MTZ Position: Q2 2026 in Review

&Partners increased its MasTec (MTZ) stake by 16% in Q2 2026, buying an estimated $174K and bringing the position to 3,342 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #1193.

&Partners first reported a position in MTZ in Q2 2023 and has held it in 9 quarters since. 911 funds tracked by Wall St. Rank hold MTZ as of Q2 2026.

  • &Partners held 3,342 shares of MasTec worth $1.48M as of Q2 2026.
  • &Partners bought 454 MasTec shares in Q2 2026, an estimated $174K.
  • MasTec made up 0.01% of &Partners's portfolio in Q2 2026, its #1193 holding.
  • &Partners first reported a position in MasTec in Q2 2023 and has held it in 9 quarters since.
  • 911 funds tracked by Wall St. Rank held MasTec as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.